| scholarly article | Q13442814 |
| P2093 | author name string | Boyd D | |
| Kim P | |||
| Florent G | |||
| Brattain M | |||
| P4510 | describes a project that uses | HCT 116 | Q28334584 |
| CBS | Q54808689 | ||
| FET | Q54834763 | ||
| GEO | Q54835723 | ||
| HCT 116b | Q54882003 | ||
| RKO | Q54950538 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colon carcinoma | Q18554829 |
| cell line | Q21014462 | ||
| P304 | page(s) | 3112-3116 | |
| P577 | publication date | 1988-06-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines | |
| P478 | volume | 48 |
| Q31161522 | A novel RNA sequencing data analysis method for cell line authentication |
| Q72236634 | Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells |
| Q41011016 | Butyrate and the colonocyte. Implications for neoplasia |
| Q35833965 | Cathepsin B and other proteases in human colorectal carcinoma |
| Q34393426 | Cell associated urokinase activity and colonic epithelial cells in health and disease |
| Q35140085 | Circulating exosomal microRNAs as biomarkers of colon cancer. |
| Q24644027 | DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells |
| Q36433505 | Decreased level of PDCD4 (programmed cell death 4) protein activated cell proliferation in the lung of A/J mouse |
| Q41613899 | Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line |
| Q42478423 | Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization |
| Q43107815 | E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells |
| Q34326087 | Effects of activin and TGFβ on p21 in colon cancer |
| Q40809560 | Effects of pCIneo and pCEP4 expression vectors on transient and stable protein production in human and simian cell lines |
| Q34290829 | Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line |
| Q35094428 | Heterogeneity of Tie2 expression in tumor microcirculation: influence of cancer type, implantation site, and response to therapy |
| Q40489756 | Hormonal regulation of the fibrinolytic components in the ovary |
| Q34330943 | Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase |
| Q34997475 | In vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancer |
| Q37629550 | In vivo safety, biodistribution and antitumor effects of uPAR retargeted oncolytic measles virus in syngeneic cancer models |
| Q54637364 | Isolation and characterization of cell lines with reduced urokinase binding. |
| Q42756488 | Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans |
| Q40995411 | Molecular evolution of versatile derivatives from a GFP-like protein in the marine copepod Chiridius poppei |
| Q39630626 | Phosphatase PRL-3 Is a Direct Regulatory Target of TGFβ in Colon Cancer Metastasis |
| Q73141201 | Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro |
| Q24307660 | Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells |
| Q51577479 | Relationship between TMEM16A/anoctamin 1 and LRRC8A. |
| Q36491792 | Relationship between expression of laminin and pathological features in human colorectal carcinoma |
| Q37166903 | Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells |
| Q41307090 | Role of the E-cadherin/alpha-catenin complex in modulating cell-cell and cell-matrix adhesive properties of invasive colon carcinoma cells |
| Q34379086 | Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro |
| Q38256796 | TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy |
| Q40931728 | Targeted disruption of the K-ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis |
| Q36531324 | The integrin alpha 6 beta 4 is a laminin receptor |
| Q35477781 | The plasminogen-plasmin system in malignancy |
| Q36382514 | The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae |
| Q55401040 | Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines. |
| Q35795105 | Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma |
| Q43270446 | Urokinase receptor expression involves tyrosine phosphorylation of phosphoglycerate kinase |
| Q41083036 | Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells |
| Q42131114 | Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas |
Search more.